Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07461142) titled 'Reduction of Hematologic Toxicity in Locally Advanced Cervical Cancers' on Feb. 26.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Institut Paoli-Calmettes

Condition: Cervical Cancer by FIGO Stage 2018

Intervention: Radiation: radiotherapy with bone marrow contouring

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 15, 2026

Target Sample Size: 72

To know more, visit https://clinicaltrials.gov/study/NCT07461142

Published by HT Digital Content S...